New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma

Hepatology

Volumn 27, Issue 4, 1998, Pages 943-950

  Scuric, Zorica ^a   Stainn, Steven C ^a   Anderson, W French ^a   Hwang, Jung Joo ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; FIBROBLAST GROWTH FACTOR; MESSENGER RNA; UNCLASSIFIED DRUG; VAS DEFERENS PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FAMILY; VAS DEFERENS;

ALDEHYDE REDUCTASE; AMINO ACID SEQUENCE; ANIMALS; BLOTTING, NORTHERN; CARCINOMA, HEPATOCELLULAR; DNA, COMPLEMENTARY; HUMANS; LIVER NEOPLASMS; MICE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0031925073     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270408     Document Type: Article

References (20)

1. Nishida N, Fukuda Y, Ishizaki K. Molecular aspects of hepatocarcinogenesis and their clinical implications. Int J Oncol 1994:4:615-622.
2. McGlynn KA, Rosvold EA, Lustbader ED, Hu Y, Clapper ML, Zhou T, Wild CP, et al. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin Bl. Proc Natl Acad Sci U S A 1995;92:2384-2387.
3. Farber E. Perspectives in cancer research. The multistep nature of cancer and development. Cancer Res 1984;44:4217-4223.
4. Farber E. Some emerging general principles in the pathogenesis of hepatocellular carcinoma. Cancer Surveys 1986;5:695-718.
5. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993;9:138-141.
6. Walker GJ, Hayward NK, Falvey S, Cooksly WGE. Loss of somatic heterozygosity in hepatocellular carcinoma. Cancer Res 1991;51:4367-4370.
7. Nishida N, Fukuda Y, Kokuryu H, Sadamoto T, Isowa G, Honda K, Yamaoka Y, et al. Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma. Int J Cancer 1992;51:862-868.
8. Fujimory M, Tokino T, Hino O, Kitahawa T, Imamura T, Okamoto E, Mitsunobu M, et al. Allelotype study of primary hepatocellular carcinoma. Cancer Res 1991;51:89-93.
9. Boige V, Laurent-Puig P, Fouchet P, Flejou JF, Monges G, Bedossa P, Bioulac-Sage P, et al. Concerted nonsynthetic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype. Cancer Res 1997;57:1986-1990.
10. Katagiri T, Nakamura Y, Miki Y. Mutations in the BRCA2 gene in hepatocellular carcinomas. Cancer Res 1996;56:4575-4577.
11. De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet 1995;11:447-449.
12. Cai J, Sun WM, Hwang J-J, Stain SC, Lu SC. Changes in S-adenosylmethionine synthetase in human liver cancer: molecular characterization and significance. HEPATOLOGY 1996;24:1090-1097.
13. Li X, Nong Z, Ekstrom C, Larsson E, Nordlinder H, Hofmann WJ, Trautwein C, et al. Disrupted IGF2 promoter control by silencing of promoter PI in human hepatocellular carcinoma. Cancer Res 1997;57:2048-2054.
14. Cote GJ, Lastra BA, Cook JR, Huang DP, Chiu JE Oncogene expression in rat hepatomas and during hepatocarcinogenesis. Cancer Lett 1985;26:121-127.
15. Tada M, Omata M, Ohio M. Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing. Cancer Res 1990;50:1121-1124.
16. Leon M, Kew MC. Analysis of ras gene mutations in hepatocellular carcinoma in southern African blacks. Anticancer Res 1995;15:859-861.
17. Zhang X, Xu HJ, Murakami Y, Sachse R, Yashima K, Hirohashi S, Hu SX, et al. Deletions of chromosome 13q, mutations in retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res 1994;54:4177-4182.
18. Nishida N, Fukuda Y, Kokuryu H, Toguchida J, Yandell DW, Ikenaga M, Imura H, et al. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res 1993;53:368-372.
19. Christa L, Simon MT, Flinois JP, Gebhardt R, Brechot C, Lasserre C. Overexpression of glutamine synthetase in human primary liver cancer. Gastroenterology 1994;106:1312-1320.
20. Peng SY, Lai PL, Chu JS, Lee PH, Tsung FT, Chen DS, Hsu HC. Expression and hypomethylation of α-fetoprotein gene in unicentric and multicentric human hepatocellular carcinoma. HEPATOLOGY 1993;17:35-41.